Horrified: Dungeons & Dragons has been announced, bringing several legendary characters and creatures to the tabletop franchise ...

Tempus AI will collaborate with Northwestern University's neurogenomics researchers to use artificial intelligence to accelerate discovery of treatments for Alzheimer's disease, the Chicago-based ...

Demeo's DnD spinoff debuts gameplay and reveals release window Building on top of the beloved virtual tabletop RPG Demeo, Dungeons and Dragons Battlemarked is headed for both Steam and VR headsets.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced that ten abstracts have been accepted for ...

Tempus AI is a healthcare-oriented artificial intelligence company. Spruce Point Capital Management released a report critical of Tempus AI this week. Investors should exercise caution with Tempus ...

Tempus AI’s stock took a hit in trading May 28, falling 19% to $53.20 during the day following a short seller’s report that claimed the Chicago-based health tech company’s share price faces ...

There are a lot of deities in Dungeons and Dragons, but some are much more interesting than others if you want to play a cleric.

We have an exclusive excerpt from Delilah S. Dawson's new book, Dungeons & Dragons: Ravenloft: Heir of Strahd, and it is bloody good!

Tempus AI reassured investors that its major pharma contracts remain strong despite funding and tariff pressures.

Tempus AI reports first-quarter revenue of $255.74 million, beating estimates of $248.13 million. The AI-focused precision medicine and patient care company reports a first-quarter adjusted loss ...

To further expand its support of phase I trials, Tempus has formed the TIME Precision Network, a group of investigators leading the phase I study platform with a focus on activating and enrolling ...

Tempus Publishes Study Validating the Benefits of xF+, its Comprehensive Liquid Biopsy Assay for Therapy Selection The validation study recently published in the Journal of Molecular Diagnostics ...